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Abstract
Liþ/Mg2þ competition has been implicated in the therapeutic action of Liþ treatment in bipolar illness. We hypothesized that this
competition depended on cell-specific properties. To test this hypothesis, we determined the degree of Liþ transport, immobilization, and
Liþ/Mg2þ competition in lymphoblastomas, neuroblastomas, and erythrocytes. During a 50 mmol/L Liþ-loading incubation, Liþ
accumulation at 30 min (mmoles Liþ/L cells) was the greatest in lymphoblastomas (11:1 0:3), followed by neuroblastomas (9:3  0:5),
and then erythrocytes (4:0  0:5). Liþ binding affinities to the plasma membrane in all three cell types were of the same order of
magnitude; however, Liþ immobilization in intact cells was greatest in neuroblastomas and least in erythrocytes. When cells were loaded
for 30 min in a 50 mmol/L Liþ-containing medium, the percentage increase in free intracellular [Mg2þ] in neuroblastoma and
lymphoblastoma cells (55 and 52%, respectively) was similar, but erythrocytes did not exhibit any substantial increase (6%).
With the intracellular [Liþ] at 15 mmol/L, the free intracellular [Mg2þ] increased by the greatest amount in neuroblastomas (158%),
followed by lymphoblastomas (75%), and then erythrocytes (50%). We conclude that Liþ immobilization and transport are related to
free intracellular [Mg2þ] and to the extent of Liþ/Mg2þ competition in a cell-specific manner.
# 2003 Elsevier Inc. All rights reserved.
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1. Introduction
Elucidation of the therapeutic effect(s) of Liþ treatment
will provide insight into the biochemical abnormality
present in bipolar disorder. Because Liþ and Mg2þ have
similar ionic potentials, Liþ was proposed to compete with
Mg2þ for Mg2þ binding sites in biomolecules [1]. Evi-
dence for this ionic competition has been observed with
nucleotides [2], PMs [3], and human RBCs [4]. It has also
been demonstrated that Liþ/Mg2þ competition can occur
in human neuroblastoma cells [5], a nerve cell model, even
at therapeutic [Liþ]i levels after chronic Li
þ treatment,
where the percentage increase in [Mg2þ]f was between 11
and 37% [6]. These increases are small; however, larger
increases in [Mg2þ]f would be toxic to cells [7], and are not
required to have a significant effect on the activity of
signal-transduction processes [8,9]. It is necessary to
determine the dependence of Liþ/Mg2þ competition on
the kinetic and thermodynamic properties of [Liþ]i,
because these properties are known to vary among different
cell types [10].
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Abbreviations: AA, atomic absorption; cP, centipoise; DIDS, 4,40-
diisothiocynostilbene-2,20-disulfonic acid; HBS, HEPES-buffered saline;
HMA, 5-(N,N0-hexamethylene)-amiloride; HTmDOTP4, thulium(III)
1,4,7,10-tetraazacyclododecane-N,N0,N00,N00 0-tetramethylenephosphonate;
kin and kout, rate constants of Li
þ influx and efflux, respectively; KLi,
lithium binding constant; [Liþ]i, total intracellular Li
þ concentration;
[Liþ]ex, total extracellular Li
þ concentration; [Mg2þ]f, free intracellular
Mg2þ concentration; MRI, magnetic resonance imaging; PBS, phosphate-
buffered solution; PM, plasma membrane; RBCs, red blood cells; T1, spin–
lattice relaxation time; T2, spin–spin relaxation time; tc, correlation time;
vin and vout, initial rate constants of Li
þ influx and efflux, respectively.
Specific sites of enzyme inhibition by Liþ have been
proposed for inositol monophosphatase [11], glycogen
synthase kinase-3b [12–14], adenylate cyclase [15], and
guanine–nucleotide binding proteins [9], in which each of
the proteins is Mg2þ-dependent. Liþ/Mg2þ competition
may therefore be the underlying theme in these more
specific hypothesized mechanisms. It is important to elu-
cidate how this competition varies among different cell
types, because this may influence Liþ inhibition of these
specific site(s) of action. For example, Liþ has been
observed to exhibit different kinds of regulation of ade-
nylate cyclase in two cell types: Liþ inhibition of adenylate
cyclase, under therapeutic conditions, is observed in urin-
ary epithelia [16], whereas in adipose cells, Liþ inhibition
does not occur [17]. The Liþ/Mg2þ competition observed
within the cell may affect these enzymes, and it is impor-
tant to ascertain which cell types will be affected the most
by Liþ through the Liþ/Mg2þ competition mechanism.
Because this ionic competition may potentially explain
the therapeutic action of Liþ in the treatment of bipolar
illness, a better understanding of this mechanism may lead
to the development of less toxic drugs in its treatment. In
this study, we demonstrate in lymphoblastoma, neuroblas-
toma, and RBCs that the extent of Liþ/Mg2þ competition
depends on the cell-type specific properties of Liþ trans-
port and immobilization.
2. Materials and methods
2.1. Materials
Furaptra was purchased from Molecular Probes, and the
shift reagent, HTmDOTP4 as a sodium salt, was obtained
from Macrocyclics. All other biochemicals were purchased
from Sigma Chemical Co. The human lymphoblastoma
CCRF-CEM cell line was purchased from the American
Type Culture Collection (ATCC). The human neuroblas-
toma SH-SY5Y cell line was provided by Dr. E. Stubbs, Jr.
(Department of Neurology, Loyola University Chicago).
Human RBCs were purchased from the Life Source blood
bank.
2.2. Characterization of Liþ transport pathways in
lymphoblastoma cells
The lymphoblastoma CCRF-CEM cells were grown as
recommended by the ATCC. For both Liþ-influx and -
efflux experiments, the cells were harvested and washed
once in PBS (1090 g/5 min/48). In order to test which
pathway was involved in Liþ transport, we supplemented
the growth medium with one of the following transport
inhibitors: 0.10 mmol/L ouabain, 0.05 mmol/L DIDS,
0.10 mmol/L bumetanide, 0.10 mmol/L phloretin, and
0.10 mmol/L HMA, which inhibit Naþ/Kþ–ATPase, anion
exchange, Naþ–Kþ–Cl cotransport, and Naþ–Liþ
countertransport (for both phloretin and HMA) pathways,
respectively [10,18]. The Naþ channel activator, veratri-
dine (at 0.50 mmol/L), was also tested in these transport
experiments [10].
For Liþ influx experiments, cells were incubated (1–5%
cytocrit) in RPMI-1640 growth medium containing
20 mmol/L LiCl and supplemented with or without one
of the transport modulators. Aliquots of the Liþ-loaded
cells were washed twice in ice-cold choline-PBS (958 g/
1 min/48) [19] after the following Liþ-loading times: 5, 10,
20, 30, 40, 50, 60, 80, 100, 120, and 150 min. Pelleted cells
were lysed and measured by AA spectrophotometry [19].
For Liþ efflux experiments, the cells were incubated
(1–5% cytocrit) with 110 mmol/L LiCl-containing PBS for
30 min [5], and then washed twice with ice-cold choline-
PBS before the addition of Liþ-free RPMI-1640 growth
medium (1–5% cytocrit) in the absence or presence of the
aforementioned ion channel modulators. Liþ efflux was
measured in aliquots of this RPMI-1640 cell suspension,
which were isolated and pelleted after the same periods as
above, except that 0 min of Liþ incubation was also
measured in the efflux experiments. Pelleted cells were
prepared as described [19].
For the influx experiments, the following equation was
used:
½Liþt ¼ ½Liþ1ð1  expðkinÞðtÞÞ; (1)
where kin is the rate constant for Li
þ influx; and [Liþ]1 and
[Liþ]t are the [Li
þ]i values when the transport has reached
equilibrium or at the different times (t), respectively. Eq. (1)
was fitted to a nonlinear one-phase exponential graph. For
the efflux experiments, the following equation was used:
½Liþt ¼ ½LiþmaxexpðkoutÞðtÞ: (2)
To calculate kout by AA spectrophotometry, we fitted
Eq. (2) to a nonlinear one-phase exponential decay graph.
[Liþ]max is the estimated [Li
þ]i at time 0 for the efflux
experiments. For vin or vout estimates, the first derivatives
of Eqs. (1) and (2) at time 0 were used (vðin or outÞ ¼
kðin or outÞ½Liþð1 or maxÞ).
2.3. Comparison of Liþ influx among cell types
Lymphoblastoma cells were prepared as described
above. RBCs were prepared from whole blood by washing
three times in PBS. The neuroblastoma cells were prepared
as previously described [19]. Each cell type was incubated
in 50 mmol/L LiCl-containing PBS with measurements at
15, 30, 45, and 60 min [5]. With each measurement, the
cells were washed in ice-cold choline-PBS and lysed as
previously described [19]. Cytocrits and hematocrits were
between 1 and 5% for each transport experiment and were
measured with an IEC model MB microhematofuge. We
used a Perkin-Elmer AA spectrophotometer (AAnalyst
100) to determine [Liþ]i, and dilution was taken into
account.
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2.4. Cell viability of agarose-embedded
lymphoblastoma cells
For embedding of the cells in agarose threads, the cells
were prepared as previously described [10,20] and per-
fused with RPMI-1640 growth medium. To determine cell
viability, we monitored the intracellular pH via the
observed 31P NMR chemical shift separation between
the resonances of the a- and g-phosphates of ATP, which
was calculated by extrapolation to previously published
pH-dependent chemical shift values [21]. The intracellular
ATP concentration was assessed by the ratio of the peak
areas of the b-phosphate of ATP over Pi ([b-ATP]/[Pi]); this
was a modification of a method in which the sum of each
area of the ATP phosphate peaks over Pi was used [20].
These 31P NMR experiments were performed on a Varian
Unity-500 spectrometer (202.9 MHz) with 2400 transients,
608 pulses, a 0.998 s acquisition time with proton decou-
pling, 19,968 data points, 0.55 s delay time, 20 Hz line
broadening, and a total accumulation time of 1 hr.
2.5. Liþ binding and immobilization to plasma
membranes and intact cells
For 7Li NMR relaxation measurements, the agarose-
embedded lymphoblastoma cells were perfused in 7 mmol/
L LiCl-containing RPMI-1640 growth medium supple-
mented with 3 mmol/L HTmDOTP4 for 3 hr in order
to resolve the intracellular 7Li resonance [10]. Cell viabi-
lity was determined at the conclusion of each experiment
using the Trypan blue dye exclusion assay [22]. The [Liþ]i
(in mmoles Liþ/L cells) values in lymphoblastoma cell
suspensions were determined by AA spectrophotometry
after 3 hr in 7 mmol/L LiCl-containing growth medium.
The lymphoblastoma [23], neuroblastoma [24], and
RBC [25] PMs were prepared, and the final PM pellet
was washed twice in 5 mmol/L Tris–Cl buffer (pH 7.3) and
stored at 80.08 for less than 2 weeks before use. Because
viscosity affects relaxation rates [26], the viscosity was
adjusted to 5 cP with polyvinyl pyrrolidone (MW-
360,000); 5 cP is a reasonable estimate of intracellular
viscosity [27]. The viscosities were measured with a
Brookfield Cone Plate viscometer. The protein concentra-
tion was determined by the method of Bradford [28].
7Li NMR relaxation measurements were conducted on a
Varian VXR-400S NMR spectrometer equipped with a
multinuclear 10 mm broadband probe at 155.4 MHz. 7Li
NMR T1 and T2 relaxation measurements were determined
using the inversion recovery and the Carr–Purcell–Mei-
boom–Gill pulse sequences [26], respectively. We used the
7Li NMR T1 values, obtained during a Li
þ titration, to
determine KLi to the PM fractions as previously described
[26,29]. Each relaxation value was determined by use of
seven delay values, with at least two transients per delay
value, an acquisition time of 0.979 s, and 19,584 data
points.
2.6. Interpretation of the [7Li] NMR relaxation
measurements
For qualitative assessment of the relaxation data, the
physical meaning of the T1, T2, T1/T2, and tc (a scale of Li
þ
motion) NMR parameters needs to be explained. When the
tc value of 7Li is short with respect to the NMR frequency,
the ion is free, resulting in T1  T2. When Liþ binds, the
value tc becomes greater than the NMR frequency, result-
ing in T1 > T2. Only one type of Li
þ binding site is
generally assumed to be present, as well as mono-expo-
nential relaxation of the 7Li nucleus, and fast exchange of
Liþ between free and bound states [26]. These are reason-
able assumptions, considering the lability and low associa-
tion constants associated with Liþ binding (even for a
tridentate ligand-like ATP) [2,3], the lack of sensitivity of
the chemical shift and relaxation times of the 7Li nucleus to
the type of coordinating atoms present in its binding site(s)
and its small quadrupolar coupling constant relative to
23Na [30], which lead to much longer relaxation times than
for 23Na. Based on these assumption, it can then be shown















where fb is the fraction of bound Li
þ. The T1obs and T2obs
values are each directly related to fb and KLi. The ratio of
Eqs. (3) and (4) results in ðT1=T2Þobs  ðT1=T2Þb, which
indicates that the T1/T2 ratio is independent of fb, and
therefore also independent of KLi. Relaxation of the
7Li
nucleus is governed by a major dipolar contribution (T1dd
and T2dd) as well as a small quadrupolar contribution of the
7Li nucleus [26]. Assuming only a dipolar contribution,
when the Liþ immobilization is such that otc @ 1, where
o is the Larmor frequency of 7Li, the relaxation equations











This indicates that the dipolar contribution to the observed
T1 and T2 relaxation values is directly and inversely
proportional to tc, respectively. Furthermore, the ratio of
these dipole–dipole relaxation values, (T1/T2)dd, is directly
proportional to t2c, which makes this a sensitive measure of
the degree of immobilization. The quadrupolar contribu-
tion to 7Li relaxation, when otc @ 1 [30–33], leads to the
same conclusion: ð1=T1Þq / qzzt1c , ð1=T2Þq / qzztc, so
that ðT1=T2Þq / t2c (where qzz is the electrical field gradient
at the nucleus, which is assumed to have axial symmetry).
Thus, in the present interpretation of 7Li relaxation data,
only one type of binding sites was considered, and the
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T1/T2 ratio was used as a measure of correlation time and
hence Liþ immobilization (ratio of Eqs. (5) and (6)), which
is independent of the fraction of bound Liþ and Liþ
binding affinity (ratio of Eqs. (3) and (4)). We used the
T1 and T2 values independently to examine fb and hence
Liþ binding (Eqs. (3) and (4)). However, the correlation
time has a direct effect on these values (Eqs. (5) and (6)).
Besides binding to a macromolecule, Liþ may also bind
to a small molecule like ATP, with a bound fraction f 0b, a
rotational correlation time t0c, and an electrical field gra-
dient q0zz. Because of the very different molecular sizes of
the macromolecule and ATP, t0c will be several orders of
magnitude shorter than tc, leading toot0c < 1. In this
extreme narrowing condition, Liþ–ATP binding will give
dipolar and quadrupolar contributions to (1/T1) and (1/T2),
which are proportional to t0c, but are negligible relative
to the contributions from Liþ–macromolecule binding. In
particular, the contribution of Liþ–ATP binding to (1/T2)q
(/ f 0bq0zzt0c) is negligible relative to that from Liþ–macro-
molecule binding (/ fbqzztc), because the two sites are
expected to have much smaller differences of electric
field gradients than of rotational correlation times,
ðq0zz=qzzÞ ! ðtc=t0cÞ.
Moreover, Liþ binds only weakly and not extensively to
a small molecule such as ATP, where K 0Li and f
0
b are small
[2,3]. Thus, even in the presence of Liþ binding to small
molecules like ATP, the relationship ðT1=T2Þobs / t2c is still
maintained. This is because t0c of ATP-bound Li
þ does not
increase much relative to that of free Liþ, and so it will not
be appreciably immobilized [2,3]. In contrast, immobiliza-
tion occurs for Liþ ions bound to macromolecular com-
ponents (i.e. tc will increase significantly) [3,26].
However, as opposed to 23Na, the visibility of the 7Li
NMR resonance would be expected to be near 100%, since
previous work has found Liþ visibility to be close to 100%
in RBC membrane suspensions [3,26] and in intact human
neuroblastoma SH-SY5Y cells [10].
2.7. Liþ/Mg2þ competition by fluorescence and
31P NMR spectroscopy
Previous work has validated the fluorescence and 31P
NMR methods for studying Liþ/Mg2þ competition and
found that the fluorescence method was the most sensitive
for cellular studies of changes in [Mg2þ]f [2,26]. In the
present study, we used fluorescence spectroscopy to mea-
sure changes in [Mg2þ]f with lymphoblastoma and neuro-
blastoma cells, but for RBCs, the 31P NMR method was
used because of the strong intrinsic fluorescence of hemo-
globin [4].
2.8. Liþ/Mg2þ competition in neuroblastoma and
lymphoblastoma cells
The cells were loaded with 10 mmol/L furaptra as pre-
viously described [19], and incubated at 378 in either
Liþ-free or 50 mmol/L LiCl-containing PBS; probenecid
and MnCl2 were used as previously described [5]. For the
fluorescence method, [Mg2þ]f was determined on a PTI
QuantaMaster QM-1 fluorimeter with the cuvette holder
water-jacketed to 378. The excitation spectrum of furaptra
was scanned between 300 and 400 nm, with the emission
set at 510 nm, and analyzed as a fluorescence intensity
ratio (335/370). For the fluorescence experiments, [Mg2þ]f
was calculated as previously described [2].
2.9. Liþ/Mg2þ competition in RBCs
RBCs were prepared by washing of whole blood three
times with PBS and then suspension of cells at 50%
hematocrit in PBS (Liþ-free) or at 1–5% hematocrit in
either 50 mmol/L LiCl-containing PBS for 30 min or
150 mmol/L LiCl-containing HBS for 60 min [18]. The
Liþ-loaded RBCs were centrifuged and resuspended at
50% hematocrit in the respective Liþ-containing buffer for
the 31P NMR measurements. For the 31P NMR experi-
ments, intracellular [Mg2þ]f was calculated as previously
described [2]. Because the RBC experiments were per-
formed under modified hematocrit conditions, we assessed
whether the 30 min 31P NMR measurement period affected
the [Liþ]i in the RBCs for both Li
þ conditions.
The 31P NMR experiments were performed on a Varian
Unity-400S NMR spectrometer (161.9 MHz) with 1200
transients, a 608 pulse, 0.800 s acquisition time with proton
decoupling, 16,000 data points, 0.5 s delay time, 20 Hz line
broadening, and a total accumulation time of 26 min [10].
2.10. Statistical analyses
To test for statistical differences between pairs of means,
we used independent sample t-tests. To test the statistical
significance of hypothesized patterns of differences across
multiple sample means, we used planned orthogonal
between-group contrasts [34]. We used one-way ANOVA
as a test of homogeneity in sample means across multiple
experimental conditions that we did not expect to differ.
We used a sequentially rejective Bonferroni-type proce-
dure [35] to control for inflation in the Type I error rate
when conducting multiple statistical comparisons.
3. Results
3.1. Liþ transport pathways in lymphoblastoma cells
We investigated Liþ influx and efflux in lymphoblas-
toma cells in the presence of different transport pathway
modulators. We used orthogonal between-group contrasts
to test the hypothesized pattern of mean differences in kin
and vin values across the seven experimental conditions
(control, veratidine, ouabain, DIDS, phloretin, HMA, and
bumetadine), specifying a priori weights of 1, 1, 6, 1, 1,
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1, and 1 for the means of the seven conditions, respectively
(Fig. 1A). As hypothesized that ouabain inhibited Liþ
influx, the planned contrast was statistically significant
for both kin (tð67Þ ¼ 5:76, one-tailed P < 0:0001), and
vin (tð67Þ ¼ 3:97, one-tailed P < 0:0001), indicating that
ouabain was the only modulator that produced a significant
effect on Liþ influx as compared to the control condition
(Fig. 1A). These findings indicate that Naþ/Kþ–ATPase is
a major Liþ influx pathway in lymphoblastoma cells.
We also used orthogonal between-group contrasts to test
the hypothesized pattern of mean differences in kout and vout
values across the seven experimental conditions (see above),
specifying a priori weights of 2, 2, 2, 2, 5, 5, and 2
for the means of the seven conditions, respectively (Fig. 1B).
As hypothesized that HMA and phloretin inhibited Liþ
efflux, the planned contrast was statistically significant
for kout (tð35Þ ¼ 7:01, one-tailed P < 0:0001), and vout
(tð35Þ ¼ 6:32, one-tailed P < 0:0001), indicating that
HMA and phloretin were the only modulators to affect
Liþ efflux significantly as compared to the control condition
(Fig. 1B). These results support the conclusion that the Naþ–
Liþ counter transporter provides a major Liþ efflux pathway.
Results for both Liþ influx and efflux remained statistically
significant when we applied a sequentially rejective Bon-
ferroni procedure.
3.2. Comparison of Liþ transport in the three
cell types
With a 50 mmol/L LiCl-containing PBS incubation and
at 1–5% cytocrit or hematocrit (Fig. 2), the largest con-
centrations of [Liþ]i as determined by AA spectrophoto-
metry were accumulated by lymphoblastoma cells,
followed by neuroblastoma cells, and then by RBCs. We
used an orthogonal between-group contrast to test this
pattern of Liþ accumulation across the three cell types
within each time point (15, 30, 45, and 60 min), specifying
a priori weights of 1, 0, and 1 for the means of lym-
phoblastoma, neuroblastoma, and RBCs, respectively.
Confirming our hypotheses, the planned contrast was
statistically significant at each of the four time points,
tð57Þ > 12:15, one-tailed P < 0:0001. Thus, the predic-
ted pattern of means for the three cell types, i.e.
lymphoblastoma > neuroblastoma > RBC, fitted the data
significantly better than expected by chance, collapsing
across the four time points.
Fig. 1. Liþ transport pathways in human lymphoblastoma CCRF-CEM cells. Liþ influx (A) transport rates (kin, white bars and vin, black bars) and Li
þ efflux
(B) transport rates (kout, white bars and vout, black bars) in the presence of modulators for the following pathways (modulators indicated in parentheses):
voltage-sensitive Naþ channels (veratridine), Naþ/Kþ–ATPase (ouabain), anion exchange (DIDS), Naþ–Liþ countertransport (phloretin and HMA), and
Naþ–Kþ–Cl cotransport (bumetanide) pathways in human lymphoblastoma cells. () Indicates a statistically significant effect (P < 0:05) compared to the
control condition. For control experiments, N > 20, whereas for the experimental conditions, N  3. Values represent means SEM. The left y-axes
correspond to kin or kout (min
1), and the right y-axes correspond to vin or vout (mmoles Li
þ/L of cells).
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3.3. Comparison of Liþ immobilization and binding
in the three cell types
Before performing the Liþ binding studies, we assessed
the cell viability of the agarose-embedded lymphoblas-
toma cells during the perfusion experiments. In particular,
we performed two 31P NMR experiments on lymphoblas-
toma cells with spectra acquired each hour over a 3 hr
period. The NMR chemical shift separation between the
resonances of the a- and g-phosphates of ATP remained
fairly constant at 5.1 ppm (Table 1), providing an estimate
of intracellular pH of 7.2–7.4 [21]. Additionally, the area
ratio of the b-phosphate of ATP over Pi ([b-ATP]/[Pi]), a
measure of cellular energy levels [20], remained approxi-
mately constant for both experiments (Table 1). At the
conclusion of each experiment, we also measured cell
viability by using the Trypan blue dye exclusion assay
[22] and found it to be above 95% in both trials.
Using HTmDOTP4 to separate the intra- and extra-
cellular 7Li NMR resonances, we compared the intracel-
lular 7Li NMR T1/T2 ratio at similar [Li
þ]i values
(mean  SD; mmoles Liþ/L cells; N ¼ 3) across lympho-
blastoma (3:1  0:3), neuroblastoma (2:9  0:3) [10], and
RBCs (3:5  0:4 [26]; Table 2). The large difference
between the T1 and T2 values for each of the three cell
types indicates that Liþ is highly immobilized within each
cell type. To test the hypothesis that the 7Li T1/T2 ratios for
Liþ were higher in neuroblastoma than in lymphoblastoma
cells, which were both higher than in RBCs, we used a
planned orthogonal between-group contrast, specifying a
priori weights of 1, 0, and 1 for the means of neuro-
blastoma cells, lymphoblastoma cells, and RBCs, respec-
tively. Confirming the hypothesized pattern of mean
differences, the planned contrast was statistically signifi-
cant, tð6Þ ¼ 16:76, one-tailed P < 0:0001 (Table 2).
At 4.0 mmol/L Liþ, the 7Li T1/T2 ratio values of the Li
þ-
treated PMs for the three cell types were not statistically
different, Fð2; 6Þ ¼ 0:50, P < 0:64 (Table 2). To deter-
mine the KLi values, we titrated the PM fractions at
constant plasma protein concentration (8:0  0:5 mg/
mL) with 2–12 mmol/L LiCl and with 500 mmol/L LiCl.
The KLi values (in M
1) of the PMs in the lymphoblastoma
cells, neuroblastoma cells, and RBCs were 340  53
(N ¼ 4), 340  42 (N ¼ 5), and 185  27 ([26]; N ¼ 5),
respectively. To test the hypothesis that PMs from neuro-
blastoma and lymphoblastoma cells would have equivalent
mean KLi values and would both have higher mean KLi
values as compared to PMs from RBCs, we used a planned
orthogonal between-group contrast, specifying a priori
weights of 1, 1, and 2 for the means of neuroblastoma
cells, lymphoblastoma cells, and RBCs, respectively. Con-
firming the hypothesized pattern of mean differences, the
planned contrast was statistically significant, tð11Þ ¼ 6:75,
one-tailed P < 0:0001.
3.4. Liþ/Mg2þ competition at either similar [Liþ]ex
or [Liþ]i
For each cell type, the [Mg2þ]f values (Fig. 3A) and the
percentage changes in [Mg2þ]f from the resting [Mg
2þ]f
values (Fig. 3B) are shown under both similar [Liþ]ex or
[Liþ]i conditions. For the similar [Li
þ]ex condition, the
[Liþ]i values (in mmoles Li
þ/L of cells) after 30 min
incubation in 50 mmol/L LiCl-containing PBS, as deter-
mined by the AA method (at 1–5% cytocrit for each cell
Fig. 2. Intracellular Liþ accumulation in three cell types. Comparison of
[Liþ]i (in mmoles Li
þ/L cells; N ¼ 5) in human lymphoblastoma (~),
neuroblastoma (&), and RBCs (5) in 50 mmol/L LiCl PBS over a 60-min
period. Values represent means  SEM.
Table 1
Cell viability of lymphoblastoma cells during two 31P NMR perfusion
experiments by use of the chemical shift (dag) and area parameters as
probes of the intracellular pH and ATP levels, respectively
Trial Time (hr) dag (ppm) [b-ATP]/[Pi]
1 1 5.07 0.18
2 5.02 0.20
3 5.00 0.20




7Li NMR relaxation values in human lymphoblastoma cells, human
neuroblastoma cells, and human RBCs, as well as for their plasma
membranesa
Sampleb [Liþ]i
c T1 (s) T2 (s) T1/T2
Lymphoblastoma cells 3.1  0.3 2.6  0.4 0.06  0.01 43  4
Neuroblastoma cells 2.9  0.3 5.1  0.8 0.05  0.02 100  10
RBCs 3.5  0.4 6.5  0.2 0.5  0.01 14  1
Lymphoblastoma PMd 4.0 11.5  1.3 0.06  0.01 207  23
Neuroblastoma PMd 4.0 12.7  0.9 0.05  0.01 236  73
RBC PMd 4.0 12.1  0.5 0.06  0.01 198  33
a Means SD, N ¼ 3 are presented.
b Data represent a compilation of new data and previous work [10,26].
c The intracellular Liþ concentration units are in mmoles Liþ/L of
cells.
d Protein concentration was 8:0 0:5 mg/mL and viscosity
5:0  0:5 cP.
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type; N ¼ 5), were 11:1  0:3, 9:3  0:5, and 4:0  0:5 for
the lymphoblastoma, neuroblastoma, and RBCs, respec-
tively (Fig. 2; for statistical analysis, see third paragraph
of Section 3). For the similar [Liþ]i condition, the [Li
þ]i
values (in mmoles Liþ/L of cells), as determined by AA (at
1–5% cytocrit for each cell type; N ¼ 5), were 14:5  1:2,
15:1  2:3, and 16:6  1:2 for the lymphoblastoma cells,
neuroblastoma cells, and RBCs, respectively. ANOVA
revealed that these three means were not significantly
different from one another, Fð2; 12Þ ¼ 2:15, P < 0:16.
Because the measured [Liþ]i values were higher in cells
loaded with Liþ under the similar [Liþ]i condition than
those in cells loaded using the similar [Liþ]ex condition,
and cells lacking Liþ in the Liþ-free condition, we first
hypothesized that higher [Liþ]i values would produce
larger increases in the [Mg2þ]f values for each cell type.
Therefore, we used between-group orthogonal contrasts to
test the hypothesis that the similar [Liþ]i condition (þ1)
had a higher [Mg2þ]f value than did the similar [Li
þ]ex
condition (0), which, in turn, had a higher [Mg2þ]f value
than did the Liþ-free condition (1), collapsing across the
three cell types, tð29Þ ¼ 2:62, one-tailed P < 0:007
(Fig. 3A), which confirms that the competition is greater
in the presence of more [Liþ]i. Also supporting our
hypotheses, a between-group orthogonal contrast indicated
that the percentage change in [Mg2þ]f was greater for the
similar [Liþ]i condition (þ1) than for the similar [Liþ]ex
condition (1), collapsing across the three types of cells,
tð19Þ ¼ 3:14, one-tailed P < 0:003. For each cell type, this
indicates that the competition was greater when more
[Liþ]i was in the cell.
Because the resting state [Mg2þ]f values are different for
each cell type (Fig. 3A), it is not appropriate to compare
the mean values of [Mg2þ]f of the three types of cells.
Therefore, we used the percentage change in [Mg2þ]f when
comparing Liþ/Mg2þ competition among cell types
(Fig. 3B). We hypothesized that, under similar [Liþ]ex
conditions, the extent of the Liþ/Mg2þ competition will
be similar in lymphoblastoma and neuroblastoma cells,
and much less in RBCs (Fig. 3B; black bars). Confirming
hypotheses, between-group orthogonal contrasts of the
percentage change in [Mg2þ]f indicated that neuroblas-
toma cells (þ1) had a similar percentage change in [Mg2þ]f
as lymphoblastoma cells (þ1); both had higher percentage
changes in [Mg2þ]f than did RBCs (2), collapsing across
experimental conditions, tð8Þ ¼ 6:35, one-tailed P <
0:0001. In addition, within the similar [Liþ]ex condition,
there was no significant difference between neuroblastoma
Fig. 3. Effect of Liþ incubation on free intracellular [Mg2þ] in three cell types. [Mg2þ]f (in mmol/L) (A) and percentage increase in [Mg
2þ]f from the resting
state [Mg2þ]f (B) in human lymphoblastoma cells (N ¼ 3), human neuroblastoma cells ([5]; N ¼ 4), and human RBCs (N ¼ 3) under Liþ-free conditions
(white bars, only in Fig. 3A), when the cells were loaded for 30 min in 50 mmol/L LiCl PBS (black bars), and when the [Liþ]i was approximately 15 mmol/L
(striped bars). Values in (A) represent means  SD and values in (B) represent means  SEM.
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and lymphoblastoma cells in the percentage change of
[Mg2þ]f (tð6Þ ¼ 0:41, two-tailed P < 0:70). These data
indicate that, under similar [Liþ]ex loading conditions,
the extent of the Liþ/Mg2þ competition will be similar
in lymphoblastoma and neuroblastoma cells, and much less
in RBCs.
The percentage changes in [Mg2þ]f for the three cell
types after [Liþ]i reached 15 mmol/L (striped bars) are
shown Fig. 3B. We hypothesized that under similar [Liþ]i
conditions, neuroblastoma cells would show the greatest
percentage change in [Mg2þ]f followed by lymphoblas-
toma cells and the least change in RBCs. Confirming our
hypothesis, a between-group orthogonal contrast indicated
that neuroblastoma cells (þ1) showed a greater percentage
change in [Mg2þ]f than did lymphoblastoma cells (0),
which, in turn, showed greater percentage changes in
[Mg2þ]f than did RBCs (1), collapsing across experi-
mental conditions, tð18Þ ¼ 3:46, one-tailed P < 0:002.
The different extent of percentage changes in [Mg2þ]f is
likely due to the different degrees of Liþ immobilization in
the three cell types (see Table 2).
For [Mg2þ]f measurements, fluorescence spectroscopy
was used with lymphoblastoma and neuroblastoma cells,
but the 31P NMR method was used for RBCs, because of
the strong intrinsic fluorescence of hemoglobin, which
required modified hematocrit conditions (see Section 2).
Therefore, we assessed whether the [Liþ]i values in RBCs
were affected during the 31P NMR measurements. For the
50 mmol/L LiCl-containing PBS condition, the [Liþ]i
value (mmoles Liþ/L cells) was determined at 50% hema-
tocrit after the NMR measurement period was completed
(30 min) to be 3:9  1:1 (N ¼ 5), which is not significantly
different from 4:0  0:5 (N ¼ 5), which was observed after
30 min of incubation at 1–5% hematocrit in 50 mmol/L
LiCl-containing PBS, tð8Þ ¼ 0:10, two-tailed P < 0:93.
For the 150 mmol/L LiCl-containing HBS condition, the
mean value of [Liþ]i (mmoles Li
þ/L cells) at 50% hema-
tocrit was 15:1  1:1 (N ¼ 5) after the 30 min NMR
measurement period, which is not significantly different
from 16:6  1:2 (N ¼ 5), which was observed at 1–5%
hematocrit after 60 min in 150 mmol/L LiCl-containing
HBS, tð8Þ ¼ 2:06, two-tailed P < 0:08.
4. Discussion
4.1. Comparison of Liþ transport properties
Liþ transport pathways have been shown to be cell-type
specific [10,36,37]. Because ouabain affected Liþ influx
(Fig. 1A), we conclude that Naþ/Kþ–ATPase provides a
major Liþ influx pathway in lymphoblastoma cells. In
RBCs and excitable cells [36], Naþ/Kþ–ATPase was
shown not to be a major Liþ influx path in the presence
of physiologic levels of Naþ and Kþ. The major Liþ influx
pathway in RBCs under physiologic conditions is the
DIDS-sensitive anion exchange pathway [36]. For the
lymphoblastoma transport experiments, there was suffi-
cient carbonate in the growth medium to form a complex
with Liþ, which is necessary for transport of Liþ by the
anion exchange pathway [36]. However, this pathway was
shown not to be a major influx pathway in lymphoblastoma
cells (Fig. 1A) or in neuroblastoma cells [10]. In human
neuroblastoma SH-SY5Y cells and other excitable cells, it
has been shown that voltage-gated Naþ channels provide
the major contribution to Liþ influx [10,36]. However, the
lymphoblastoma cell line has only low amounts of voltage-
gated Naþ channels [38]. Therefore, as expected, veratri-
dine did not alter Liþ transport in these cells.
In RBCs, the Naþ/Liþ countertransport pathway is a
major Liþ efflux pathway [36]. Liþ efflux in nerve cells is
thought to occur via a countertransport mechanism (pos-
sibly Naþ/Liþ countertransport) [36]. With human neuro-
blastoma cells, phloretin, a Naþ/Liþ countertransport
blocker, did not inhibit Liþ efflux [10], which may be
due to the low specificity of this blocker as compared to the
more specific inhibitor, HMA [18]. In our study, both
blockers, HMA and phloretin, produced a significant effect
by decreasing the Liþ efflux rates in lymphoblastoma cells,
in which HMA produced the largest effect (Fig. 1B).
Therefore, Naþ/Liþ countertransport is the major Liþ
efflux pathway in lymphoblastoma cells and RBCs, and
possibly in excitable cells.
Lymphoblastoma and neuroblastoma cells have mem-
brane potentials in the range of 50 to 90 mV [38]. In
contrast, RBCs have a membrane potential of 10 mV
[36]. Because lymphoblastoma and neuroblastoma cells
have similar and larger membrane potentials as compared
to RBCs, one would predict that lymphoblastoma and
neuroblastoma cells should accumulate much more Liþ
than do RBCs. The accumulation of Liþ in these cell types
partially follows this trend (Fig. 2); however, the variations
in Liþ transport pathways presumably cause further Liþ
accumulation differences in the three cell types.
4.2. Comparison of Liþ binding and immobilization
In the following discussion, we use the 7Li NMR T1/T2
ratio as a measure of the Liþ correlation time to address its
immobilization and the individual T1 and T2 values for Li
þ
binding (see Section 2 for interpretation of NMR relaxation
measurements and distinction between binding and immo-
bilization). As seen in Table 2, the 7Li NMR T1/T2 ratio is
greatest in neuroblastoma cells, less in lymphoblastoma
cells, and least in RBCs. This indicates that the correlation
time of the Liþ nuclei and Liþ immobilization is largest in
neuroblastoma cells and smallest in RBCs. Because the 7Li
NMR T1/T2 ratios are approximately equal for each PM
fraction, Liþ immobilization is similar among the PM
fractions studied. A comparison of the PM fractions to
the intact cells in regard to the 7Li NMR T1/T2 ratio is not
valid, because the plasma membrane protein concentration
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in the intact cells will vary between cell types, and cannot
be compared to the PM fractions in which the protein
concentration was controlled.
Because the plasma membrane is the major Liþ binding
site in RBCs [26], we explored the possibility that the PM
affinities might explain the differences in Liþ immobiliza-
tion in the three cell types. Because the observed T1 and T2
values were similar in PM suspensions, it is not surprising
that the binding constants to the different PMs were also
found to be of the same order of magnitude. Therefore, the
differences between the intact cells in Liþ immobilization
are hypothesized to be due to Liþ immobilization to other
cell components and not Liþ immobilization by PMs.
Alternatively, this may suggest that more binding sites,
or sites with different affinities, exist in the neuroblastoma
cells as compared to the other two cell types.
4.3. Comparison of Liþ/Mg2þ competition
Under similar [Liþ]ex loading conditions, the percentage
change in [Mg2þ]f are approximately equal in lympho-
blastoma and neuroblastoma cells, whereas it is much less
in RBCs (Fig. 3). Furthermore, the total Liþ accumulation
was greatest in lymphoblastoma cells, followed by neuro-
blastoma, and then RBCs. Even though lymphoblastoma
cells accumulate a larger amount of [Liþ]i, this effect may
be canceled out by the greater degree of Liþ immobiliza-
tion, and increased competition sites present in neuroblas-
toma cells. This suggests that the effect of Liþ on Mg2þ-
dependent metabolism is more similar in lymphoblastoma
and neuroblastoma cells than in RBCs, despite differences
in Liþ transport and immobilization properties. Therefore,
we expect that, under pharmacologic conditions, these two
cell types would experience a similar extent of Liþ/Mg2þ
competition.
At a similar [Liþ]i of 15 mmol/L, the neuroblastoma
cells displayed a 158% increase in [Mg2þ]f, whereas the
lymphoblastoma cells displayed a 75% increase in
[Mg2þ]f, and RBCs an increase of 50% (Fig. 3). The
variable extent of Liþ effects on [Mg2þ]f (neuroblastoma
cells > lymphoblastoma cells > RBCs) is likely to be a
result of the different degrees of Liþ immobilization in the
three cell types (Table 2).
4.4. Relevance to therapeutic Liþ levels
It has been previously demonstrated that Liþ/Mg2þ com-
petition occurs at therapeutic [Liþ]i levels (0.8–1.5 mmol/L)
in human neuroblastoma SH-SY5Y cells [6]. In particular, it
was found that, at an [Liþ]i of 0.8 mmol/L, the percentage
change in [Mg2þ]f was 11%. Changes in [Mg
2þ]f of the
order of 11% would have a large impact on the many Mg2þ-
sensitive pathways. This reported change in [Mg2þ]f is
small; however, other work using RBC membranes has
demonstrated that Liþ at therapeutic levels will compete
with 14–21% of Mg2þ binding sites [3], and decreases the
initial activation of the a-subunit of the recombinant inhi-
bitory G protein by approximately 50% [8]. Moreover,
cytosolic [Mg2þ]f has been demonstrated to be strictly
regulated in cellular systems since large increases result
in neurotoxicity and apoptosis [7,39], while micromolar
fluctuations affect the activity of some ion channels [40].
From extrapolation of our data (Fig. 3), we used the propor-
tional relationship {percentage change in [Mg2þ]f}/[Li
þ]i to
calculate the percentage change of [Mg2þ]f at 0.8 mM [Li
þ]i
and found that there was a 3.7–4.1% and 1.2–2.4% change
for lymphoblastoma and RBCs, respectively. Based on these
calculations, it is apparent that it would be difficult to
observe this competition at therapeutic [Liþ]i levels for
every cell type. At therapeutic [Liþ]i levels, the extent of
Liþ/Mg2þ competition will be different in various cell types
and can be predicted from the transport, immobilization, and
binding properties of Liþ. Liþ/Mg2þ competition will
increase with increased immobilization, binding, and accu-
mulation of [Liþ]i.
With the recent advances in 7Li magnetic resonance
imaging (MRI) techniques, Liþ levels and binding para-
meters (T1 and T2) can be measured within various loca-
tions in the brain [41,42]. It should be possible to predict
locations in the body and brain where the greatest effect of
Liþ on Mg2þ-dependent metabolism will be observed.
Furthermore, the use of 31P MRI methods for measuring
localized [Mg2þ]f should complement these studies [43].
In summary, the effects of Liþ on Mg2þ-dependent
enzymes can be better understood with a knowledge of
the extent of the ionic competition mechanism in particular
cell types.
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